TripleBlind
Privacy-Enhancing Computation Solution | Combining Data & Algorithms While Preserving Privacy & Ensuring Compliance
Est 2019|Valuation $109M|Raised $32.2M
MarketsData Security Platforms
Published Sep 26, 2026
| Starting Price | Not publicly listed (enterprise/custom) | Not consistently published as simple SaaS tiers; pricing often depends on Snowflake usage/partner apps | Not typically self-serve; enterprise/custom |
| Best For | Cross-entity collaboration on sensitive data and algorithms using an in-place privacy approach; notable focus on healthcare use cases | Organizations standardized on Snowflake wanting governed collaboration and clean-room workflows | Teams pursuing PETs such as homomorphic encryption or federated learning for analytics/AI on encrypted data |
| Key Strength | Privacy-focused collaboration model with a healthcare compliance narrative; publicly available SDK/docs and release notes indicate product development activity | Tight integration with Snowflake ecosystem, governance, and cross-cloud collaboration patterns | Clear PET category positioning; suitable where encryption-heavy approaches are acceptable and performance-viable |
| Key Weakness | Limited public customer reviews; unclear public detail on enterprise IAM controls (SSO/SCIM) and some certifications | Constrained to Snowflake ecosystem patterns; may be less suitable for non-Snowflake architectures | Performance and complexity trade-offs common to encryption-heavy PETs; may require specialized expertise |
TripleBlind vs Snowflake clean rooms: Snowflake provides clean-room capabilities native to its platform. TripleBlind positions itself as a platform-agnostic PET layer capable of integrating with multiple environments (the vendor has described Snowflake integration capabilities in its materials). Buyers should evaluate whether a platform-agnostic PET layer or an ecosystem-native clean room better fits their operational model and existing infrastructure.
TripleBlind vs Duality: Duality often emphasizes homomorphic encryption and related PETs. TripleBlind’s marketing differentiates its approach from several PET categories and claims scalability advantages over homomorphic encryption; without independent benchmarking, these claims require validation.
Market adoption signals: Funding and partnerships with institutional healthcare and platform partners indicate institutional interest. The lack of public reviews on major review platforms is a separate signal that buyers should address through procurement diligence and reference checks.